Immediate Impact

82 standout
Sub-graph 1 of 23

Citing Papers

Sotorasib with panitumumab in chemotherapy-refractory KRASG12C-mutated colorectal cancer: a phase 1b trial
2024 Standout
Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications
2023 Standout
2 intermediate papers

Works of Arnold Cyjon being referenced

Symptom Improvement in Lung Cancer Patients Treated With Erlotinib: Quality of Life Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21
2006

Author Peers

Author Last Decade Papers Cites
Arnold Cyjon 319 289 29 64 18 425
Kazimierz Roszkowski 321 291 26 48 17 411
M.C. Pennucci 349 279 25 93 17 496
A. Termeer 222 279 34 57 13 448
Alison Norton 312 299 25 44 10 409
Michèle Natale 255 290 45 86 25 410
Yoshifumi Soejima 266 305 43 92 27 432
M. Lomas 354 408 40 93 22 504
Alistair Dorward 180 120 24 54 18 388
F. Viñas 365 299 36 70 20 461
Sjaak Burgers 327 155 19 25 20 446

All Works

Loading papers...

Rankless by CCL
2026